Trial intelligence / Profile preview

Liraglutide and Diet in Overweight or Obesity Without Diabetes

NCT07913685Phase 4Completed

Sponsor
Medical University of Białystok
Start
Apr 2023
Primary completion
Sep 2025
Countries
1
01

Overview

A Phase 4 trial of liraglutide in obesity, sponsored by Medical University of Białystok. Started Apr 2023; status: completed.

02

Drugs

03

Conditions

obesity

Beyond the preview

Go deeper on NCT07913685.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07913685.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call